Walleye Trading
AZN icon

Walleye Trading’s AstraZeneca AZN Stock Holding History

Walleye Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1M Sell
81,500
-82,800
-50% -$16M 0.03% 590
2025
Q4 		$30.2M Buy
164,300
+7,150
+5% +$1.25M 0.04% 439
2025
Q3 		$24.1M Buy
157,150
+49,500
+46% +$7.49M 0.04% 517
2025
Q2 		$15M Buy
107,650
+11,450
+12% +$1.6M 0.03% 644
2025
Q1 		$14.1M Sell
96,200
-19,300
-17% -$2.79M 0.03% 570
2024
Q4 		$15.1M Sell
115,500
-121,450
-51% -$17M 0.03% 583
2024
Q3 		$36.9M Sell
236,950
-99,100
-29% -$16M 0.08% 266
2024
Q2 		$52.4M Buy
336,050
+105,850
+46% +$15.9M 0.12% 154
2024
Q1 		$31.2M Buy
230,200
+92,950
+68% +$12.3M 0.07% 284
2023
Q4 		$18.5M Sell
137,250
-42,150
-23% -$5.48M 0.04% 477
2023
Q3 		$24.3M Buy
179,400
+94,450
+111% +$12.9M 0.06% 305
2023
Q2 		$12.2M Buy
84,950
+46,300
+120% +$6.81M 0.04% 492
2023
Q1 		$5.37M Sell
38,650
-21,950
-36% -$2.95M 0.01% 993
2022
Q4 		$8.22M Buy
60,600
+8,850
+17% +$1.11M 0.02% 783
2022
Q3 		$5.68M Buy
51,750
+18,150
+54% +$2.3M 0.02% 948
2022
Q2 		$4.44M Sell
33,600
-266
-0.8% -$34.9K 0.01% 1112
2022
Q1 		$4.49M Sell
33,866
-51,128
-60% -$6.13M 0.01% 1068
2021
Q4 		$9.9M Sell
84,994
-35,000
-29% -$4.12M 0.03% 610
2021
Q3 		$14.4M Buy
119,994
+14,494
+14% +$1.69M 0.05% 388
2021
Q2 		$12.6M Buy
105,500
+98,300
+1,365% +$10.8M 0.05% 349
2021
Q1 		$716K Sell
7,200
-4,250
-37% -$427K ﹤0.01% 2255
2020
Q4 		$1.15M Buy
11,450
+5,350
+88% +$567K 0.01% 1853
2020
Q3 		$669K Sell
6,100
-21,700
-78% -$2.41M ﹤0.01% 1993
2020
Q2 		$2.94M Buy
27,800
+1,800
+7% +$186K 0.02% 837
2020
Q1 		$2.32M Buy
26,000
+17,500
+206% +$1.65M 0.02% 737
2019
Q4 		$848K Buy
8,500
+3,400
+67% +$320K 0.01% 1948
2019
Q3 		$455K Sell
5,100
-7,850
-61% -$681K ﹤0.01% 2235
2019
Q2 		$1.07M Sell
12,950
-5,450
-30% -$427K 0.01% 1540
2019
Q1 		$1.49M Sell
18,400
-5,700
-24% -$449K 0.01% 1313
2018
Q4 		$1.83M Buy
24,100
+17,550
+268% +$1.37M 0.01% 1136
2018
Q3 		$518K Buy
6,550
+3,600
+122% +$272K ﹤0.01% 2856
2018
Q2 		$207K Sell
2,950
-74,600
-96% -$5.37M ﹤0.01% 3616
2018
Q1 		$5.42M Buy
77,550
+12,600
+19% +$873K 0.03% 505
2017
Q4 		$4.51K Buy
64,950
+31,900
+97% +$2.15M 0.02% 737
2017
Q3 		$2.24K Sell
33,050
-10,900
-25% -$689K 0.01% 1187
2017
Q2 		$3K Sell
43,950
-75,050
-63% -$4.9M 0.02% 896
2017
Q1 		$7.41K Buy
119,000
+107,400
+926% +$6.25M 0.05% 318
2016
Q4 		$634K Sell
11,600
-6,200
-35% -$352K ﹤0.01% 1881
2016
Q3 		$1.17M Buy
17,800
+10,150
+133% +$663K 0.01% 1408
2016
Q2 		$460K Sell
7,650
-16,700
-69% -$970K ﹤0.01% 2287
2016
Q1 		$1.37M Sell
24,350
-103,800
-81% -$6.24M 0.01% 1125
2015
Q4 		$8.7M Buy
128,150
+95,300
+290% +$6.25M 0.08% 222
2015
Q3 		$2.09M Buy
32,850
+1,250
+4% +$82.2K 0.02% 645
2015
Q2 		$2.01M Buy
31,600
+30,000
+1,875% +$2.05M 0.02% 696
2015
Q1 		$109K Sell
1,600
-464,400
-100% -$32.3M ﹤0.01% 2603
2014
Q4 		$32.8M Buy
466,000
+446,200
+2,254% +$31.9M 0.3% 35
2014
Q3 		$1.41M Sell
19,800
-3,900
-16% -$285K 0.02% 634
2014
Q2 		$1.76K Buy
23,700
+21,200
+848% +$1.53M 0.02% 468
2014
Q1 		$162 Buy
2,500
+100
+4% +$6.46K ﹤0.01% 2063
2013
Q4 		$142K Buy
+2,400
New +$130K ﹤0.01% 2349
2013
Q3 		– Sell
-4,200
Closed -$199K – 2917
2013
Q2 		$199K Buy
+4,200
New +$214K ﹤0.01% 1711

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Walleye Trading's AZN Position: Q1 2026 in Review

Walleye Trading reduced its AstraZeneca (AZN) stake by 91% in Q1 2026, selling an estimated $5.03M and leaving 2,657 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Walleye Trading first reported a position in AZN in Q2 2013 and has held it in 23 quarters since. The position peaked at $9.54M in Q3 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Walleye Trading held 2,657 shares of AstraZeneca worth $524K as of Q1 2026.
  • Walleye Trading sold 26,102 AstraZeneca shares in Q1 2026, an estimated $5.03M.
  • AstraZeneca made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2565 holding.
  • Walleye Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 23 quarters since.
  • Walleye Trading's AstraZeneca position peaked at $9.54M in Q3 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.